Outcomes after intestinal transplantation: a single-center experience over a decade.
Farmer
D G
DG
Surgery, Dumont-UCLA Transplant Center, Los Angeles, California 90095-7054, USA. dgfarmer@mednet.ucla.edu
McDiarmid
S V
SV
Yersiz
H
H
Cortina
G
G
Vargas
J
J
Maxfield
A J
AJ
Vandenbogaart
B
B
Correa
M
M
Kroeber
A
A
Geevarghese
S
S
Busuttil
R W
RW
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007410:Intestinal Diseases / Q000145:classification / Q000601:surgery*; D007422:Intestines / Q000637:transplantation*; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir